1Redlinger T, Corella-Barud V, Graham J, Galindo A, Avitia R, Cardenas V. Hyperendemic Cryptosporidium and Giardia in households lacking municipal sewer and water on the United States-Mexico border. Am J Trop Med Hyg 2002; 66:794-798.
2Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001; 14:114-128.
3Liu LX, Weller PF. Antiparasitic drugs. N Engl J Med 1996;334:1178-1184.
4Hall A, Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 1993; 87:84-86.
5Koilaritsch H. Jeschko E, Wiedermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. Trans R Soc Trop Med Hyg 1993; 87:689.
6Vesy CJ, Peterson WL. The management of Giardiasis. Aliment Pharmacol Ther 1999; 13:843-850.
7Homan WL, Mank TG. Human giardiasis: genotype linked differences in clinical symptomatology. Int J Parasito1 2001; 31:822-826.
8Tessier JL, Davies G. Giardiasis. Primary Care Update for OB/GYNS 1999; 6:8-11.
9Cedillo-Rivera R, Munoz O. In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol 1992; 37:221-224.
10Misra PK, Kumar A, Agarwal V, Jagota SC. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Indian Pediat 1995; 32:779-782.
